Akari Therapeutics (AKTX) Price to Earnings (2014 - 2026)

Akari Therapeutics (AKTX) Price to Earnings (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) P/E
1 Oculis Holding AG 66,440.76 Bn 66,440.47 Bn - -31.00 Bn
2 Nanobiotix 1,909.20 Bn 1,909.14 Bn - -70,009.43
3 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn - -34,367.24
4 BeOne Medicines 468.28 Bn 463.49 Bn 1.35 Bn 912.79
5 Vertex Pharmaceuticals 122.49 Bn 115.24 Bn 2.59 Bn 28.23
6 Regeneron Pharmaceuticals 70.26 Bn 61.51 Bn 3.31 Bn 15.88
7 Belite Bio 62.88 Bn 62.88 Bn - 369.89 Bn
8 Argenx Se 55.67 Bn 50.48 Bn 1.41 Bn 32.45
9 Alnylam Pharmaceuticals 37.37 Bn 34.36 Bn 959.66 Mn 68.70
10 Revolution Medicines 37.28 Bn 37.28 Bn - -27.18

Historic Data

Download Data
DateValue
Jul 23, 2026 -37,601.81
Jul 22, 2026 -39,663.84
Jul 21, 2026 -37,601.81
Jul 20, 2026 -43,100.56
Jul 17, 2026 -44,515.69
Jul 16, 2026 -46,901.18
Jul 15, 2026 -48,801.48
Jul 14, 2026 -54,259.81
Jul 13, 2026 -54,178.94
Jul 10, 2026 -56,119.68
Jul 9, 2026 -53,208.58
Jul 8, 2026 -57,453.94
Jul 7, 2026 -62,588.81
Jul 6, 2026 -44,070.93
Jul 2, 2026 -42,089.76
Jul 1, 2026 -41,442.85
Jun 30, 2026 -41,402.42
Jun 29, 2026 -39,178.65
Jun 26, 2026 -43,383.59
Jun 25, 2026 -38,491.31